Early Imatinib Mesylate-Induced Hepatotoxicity in Chronic Myelogenous Leukaemia

Publisher： Karger

E-ISSN： 1421-9662|118|4|205-208

ISSN： 0001-5792

Source： Acta Haematologica, Vol.118, Iss.4, 2007-11, pp. : 205-208

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Promyelocytic Crisis of Chronic Myelogenous Leukaemia during Imatinib Mesylate Treatment

By  

Acta Haematologica, Vol. 117, Iss. 4, 2006-12 ,pp. : 191-196

Karger

Access to resources Recommend Favorite

The Hydrolysed Products of Iridoid Glycosides Can Enhance Imatinib Mesylate‐Induced Apoptosis in Human Myeloid Leukaemia Cells

By  

PHYTOTHERAPY RESEARCH, Vol. 29, Iss. 3, 2015-03 ,pp. : 434-443

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effect of Imatinib Mesylate Combined with Granulocyte Colony-Stimulating Factor on Leukaemic Blast Cells Derived from Advanced-Stage Chronic Myelogenous Leukaemia Patients

By  

Acta Haematologica, Vol. 116, Iss. 1, 2006-07 ,pp. : 8-18

Karger

Access to resources Recommend Favorite

Squamous cell carcinoma in a chronic myelogenous leukemia patient treated with imatinib mesylate

By  

THE JOURNAL OF DERMATOLOGY, Vol. 42, Iss. 3, 2015-03 ,pp. : 338-339

John Wiley & Sons Inc

Access to resources Recommend Favorite

Letters to the Editor

By  

INTERNAL MEDICINE JOURNAL, Vol. 45, Iss. 3, 2015-03 ,pp. : 358-359

John Wiley & Sons Inc

Access to resources Recommend Favorite